CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- FinancialsAltman Z-Score 6.74: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.87%Below 5Y avg (1.13%)
Annual Rate
CNY 0.13Paid annual
Payout Ratio
67.8%Moderate
Last Ex-Dividend
May 14, 2026
Screen for this company's dividend patterns
Find other companies where the same dividend readings fire.
High Dividend Payout With FCF And Equity Ratio
→dividend payout intensity
fcf positive 3y
ratio balance equity
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company return capital?
High Dividend Payout With FCF And Equity Ratio
It pays out most of its earnings, on three years of positive free cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.28BCNY486.94M · vs all stocks (USD)
Trailing P/E
38.90xvs Medical Devices peers
Revenue (TTM)
996.64MCNY148.02M · vs all stocks (USD)
Profit Margin
9.14%vs Medical Devices peers
Beta
0.1390xvs all stocks
52-Week Change
-8.09%vs all stocks
Market Capitalization
3.28BCNY486.94M · vs all stocks (USD)
Enterprise Value
2.76BCNY410.64M · vs all stocks (USD)
Trailing P/E
38.90xvs Medical Devices peers
Forward P/E
40.90xvs Medical Devices peers
Price to Sales (TTM)
3.50xvs Medical Devices peers
Price to Book (MRQ)
3.28xvs Medical Devices peers
Enterprise to Revenue
2.77xvs Medical Devices peers
Enterprise to EBITDA
21.46xvs Medical Devices peers
Gross Margin
37.76%vs Medical Devices peers
Profit Margin
9.14%vs Medical Devices peers
Operating Margin
12.68%vs Medical Devices peers
Return on Assets (TTM)
4.69%vs Medical Devices peers
Return on Equity (TTM)
8.75%vs Medical Devices peers
Revenue (TTM)
996.64MCNY148.02M · vs all stocks (USD)
Revenue per Share (TTM)
4.53CNYUpdated Aug 19, 2026Quarterly Revenue Growth
3.80%vs Medical Devices peers
Gross Profit (TTM)
350.58MCNY52.07M · vs all stocks (USD)
EBITDA (TTM)
119.52MCNY17.75M · vs all stocks (USD)
Net Income (TTM)
91.13MCNY13.53M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
39.80%vs Medical Devices peers
Operating Cash Flow (TTM)
158.93MCNY23.60M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
98.75MCNY14.67M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1300CNYUpdated Aug 19, 2026Trailing Annual Dividend Yield
0.87%vs all stocks
5-Year Average Dividend Yield
1.13%vs all stocks
Payout Ratio
67.78%vs Medical Devices peers
Minority Interest (Equity)
-21.39MCNYFY2025 · Dec 31, 2025Revenue
986.21MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
635.08MCNYFY2025 · Dec 31, 2025Gross Profit
351.13MCNYFY2025 · Dec 31, 2025Operating Income
105.92MCNY15.73M · vs all stocks (USD)
Pre-tax Income
84.35MCNYFY2025 · Dec 31, 2025Income Tax Expense
4.08MCNYFY2025 · Dec 31, 2025Net Income
80.27MCNYFY2025 · Dec 31, 2025EBIT
86.70MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
135.90MCNYFY2025 · Dec 31, 2025Research & Development
95.10MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
79.60MCNYFY2025 · Dec 31, 2025Other Operating Expenses
8.96MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
6.64MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
2.36MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.3770CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.3764CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
217.50MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
217.50MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
80.27MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
1.73MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
104.43MCNYFY2025 · Dec 31, 2025Free Cash Flow
90.73MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
667.73MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
80.27MCNYFY2025 · Dec 31, 2025Other Non-cash Items
10.14MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
185.37KCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
13.84MCNYFY2025 · Dec 31, 2025Capital Expenditures
-13.69MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.65BCNYFY2025 · Dec 31, 2025Sale of Investments
1.66BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-7.25MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
47.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-182.75MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-63.28MCNYFY2025 · Dec 31, 2025Other Financing Charges
-4.47MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-203.50MCNYFY2025 · Dec 31, 2025Shares Outstanding
218.61MSharesUpdated Aug 19, 2026Float Shares
147.66MSharesUpdated Aug 19, 2026% Held by Insiders
33.55%vs all stocks
% Held by Institutions
3.20%vs all stocks
Total Cash (MRQ)
740.51MCNY109.98M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.39CNYUpdated Aug 19, 2026Total Debt (MRQ)
49.44MCNY7.34M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0475xvs Medical Devices peers
Current Ratio (MRQ)
2.83xvs Medical Devices peers
Book Value per Share (MRQ)
4.86CNYUpdated Aug 19, 2026Total Assets
1.39BCNY206.65M · vs all stocks (USD)
Total Current Assets
976.39MCNYFY2025 · Dec 31, 2025Total Liabilities
388.36MCNYFY2025 · Dec 31, 2025Total Non-current Assets
414.99MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
15.48MCNYFY2025 · Dec 31, 2025Total Current Liabilities
372.88MCNYFY2025 · Dec 31, 2025Cash
666.93MCNYFY2025 · Dec 31, 2025Cash Equivalents
35.66MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
702.59MCNYFY2025 · Dec 31, 2025Other Short-term Investments
3.15MCNYFY2025 · Dec 31, 2025Accounts Receivable
166.79MCNYFY2025 · Dec 31, 2025Inventory
76.85MCNYFY2025 · Dec 31, 2025Accounts Payable
234.96MCNYFY2025 · Dec 31, 2025Short-term Debt
50.42MCNYFY2025 · Dec 31, 2025Other Current Liabilities
356.93KCNYFY2025 · Dec 31, 2025Long-term Debt
260.81KCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
1.55MCNYFY2025 · Dec 31, 2025Common Stock (Book)
217.75MCNYFY2025 · Dec 31, 2025Retained Earnings
243.20MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.00BCNY148.97M · vs all stocks (USD)
52-Week Low
11.32CNYUpdated Aug 19, 202652-Week High
17.49CNYUpdated Aug 19, 202652-Week Change
-8.09%vs all stocks
Beta
0.1390xvs all stocks
50-Day MA
13.65CNYUpdated Aug 19, 2026200-Day MA
13.88CNYUpdated Aug 19, 2026Avg 10-Day Volume
14.69MSharesUpdated Aug 19, 2026Avg 30-Day Volume
12.38MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
0.4100CNYUpdated Aug 19, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 6.74: safe zoneNotable
Altman Z-Score: 6.74
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
G2GBio Inc.
Tier 1ProductionApproval-Gated PipelineRule
ProKidney Corp
Tier 1ProductionApproval-Gated PipelineRule
Chison Medical Technologies Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
OrthoPediatrics Corp.
Tier 1ProductionApproval-Gated PipelineRule
Tuoxin Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Huaren Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Onconic Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Anhui Sunhere Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Beijing Succeeder Technology Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hyundai Bioscience Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Odontoprev S.A.
1 interpretationHigh Dividend Payout With FCF And Equity Ratio
Fastenal Company
1 interpretationHigh Dividend Payout With FCF And Equity Ratio
Castrol India Ltd.
1 interpretationHigh Dividend Payout With FCF And Equity Ratio